High-intensity Interval Training in Patients With COPD: a Fidelity and Tolerability Study
NCT ID: NCT05273684
Last Updated: 2022-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2021-11-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiopulmonary Adaptations to High-intensity Interval Training (HIIT) in COPD
NCT06551441
Pulmonary Adaptive Responses to HIIT in COPD
NCT05552833
High Intensity Interval Training and Technologies in COPD
NCT05343949
Acute Effects of Supramaximal High-Intensity Interval Training in People With COPD
NCT05874999
Supramaximal High-Intensity Interval Training in People With and Without Chronic Obstructive Pulmonary Disease
NCT06068322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each training session is evaluated by Borg Scale (5) and the Likert Scale (6), as well as time spent in with a heart rate above 85% of maximum. Each HIIT session is separated by at least a 3-day wash-out period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
4*4 followed by 10*1 or 10*1 followed by 4*4
Following baseline measurements, participants are allocated to the random sequence, by which they will complete the two HIIT protocols ⟨http://www.randomization.com⟩ and based on this, patients are randomized to a specific testing sequence.
High intensity interval training
Participants will undergo 4x4 and 1x10 minutes of interval training on two separate days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High intensity interval training
Participants will undergo 4x4 and 1x10 minutes of interval training on two separate days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-80 years
* Moderate to severe COPD(GOLD stage II to III)
Exclusion Criteria
* Known heart failure
* Previous or current coronavirus disease 2019 (COVID-19)
* Dementia or other severe neurological disease
* Known vascular
* Symptoms of disease within 2 weeks prior to the study
* Pregnancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ronan Berg
MD, DMSc, Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronan Berg, MD
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nymand SB, Hartmann J, Rasmussen IE, Iepsen UW, Ried-Larsen M, Christensen RH, Berg RMG. Fidelity and tolerability of two high-intensity interval training protocols in patients with COPD: a randomised cross-over pilot study. BMJ Open Sport Exerc Med. 2023 Mar 8;9(1):e001486. doi: 10.1136/bmjsem-2022-001486. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CFAS_2021_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.